Philip Bejon
Director Modernising Medical Microbiology
I am Director of Modernising Medical Microbiology, co-leading with Sarah Walker. I was previously Director of the KEMRI-Wellcome Trust Research Programme, a collaborative Programme formed by the Kenya Medical Research Institute (KEMRI), Wellcome and University of Oxford. I am a clinician with specialist training in infectious disease. I have an interest in the evaluation of vaccines, including malaria, yellow fever and Ebola vaccines. I have undertaken studies of naturally acquired immunity to malaria and human challenge models, and have an interest in bone infection and osteomyelitis.
Recent publications
-
Comparative performance of the InBios SCoV-2 DetectTM IgG ELISA and the in-house KWTRP ELISA in detecting SARS-CoV-2 spike IgG antibodies in Kenyan populations
Journal article
Kutima B. et al, (2024), Wellcome Open Research, 9, 349 - 349
-
Utility of MALDI-TOF MS for determination of species identity and blood meal sources of primary malaria vectors on the Kenyan coast
Journal article
Karisa J. et al, (2024), Wellcome Open Research, 8, 151 - 151
-
Distinct transcriptomic signatures define febrile malaria depending on initial infective states, asymptomatic or uninfected.
Journal article
Kimenyi KM. et al, (2024), BMC infectious diseases, 24
-
Extracellular vesicles could be a putative posttranscriptional regulatory mechanism that shapes intracellular RNA levels in Plasmodium falciparum.
Journal article
Kioko M. et al, (2023), Nature communications, 14
-
Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational study
Journal article
Kimotho J. et al, (2023), Wellcome Open Research, 8, 350 - 350